DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Jänicke F, Prechtl A, Thomssen C. et al.
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J. Natl.
Cancer Inst 2001; 93: 913-920
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.